Unijules.com

Research & Development Centre PDF Print E-mail

 

Image

 

We are a research and technology driven company with our R&D efforts focused on developing new formulations, both in the allopathic and herbal segment. Our Company has set up a Research & Development centre at Shantinagar, Nagpur. The area consist of 18,781.73 Sq. feet.

Our R&D facility comprises of research and analytical laboratories at Shantinagar, Nagpur with a team of 20 R&D personnel with expertise in the development of new dosage forms, novel drug delivery systems and specialized formulations. We employed 4 scientists and specialists for our R&D activities. We have the R&D capability and experience to develop, manufacture and register products across various formulations, dosage forms and delivery systems to increase the effectiveness of drugs and make our products better suited to market requirements.

We believe our expertise in developing complex and difficult to develop products such as converting suspensions in syrup form and complex and difficult to develop delivery systems, such as coating of herbal extracts on pellets provides us with a competitive advantage. We believe we were one of first companies in India to have developed a pellet technology system for 'PELLETS OF HERBAL EXTRACTS AND THE PROCESS OF PREPARING PELLETS' which provides us with a competitive advantage. Additionally, we have filed three (3) patent applications with WIPO for registration of (i) 'PELLETS OF HERBAL EXTRACTS AND THE PROCESS OF PREPARING PELLETS'; (ii) 'HERBAL GASTROINTENSTINAL CONTROLLED DRUG DELIVERY DOSAGE FORMS INCLUDING PELLETS AND PROCESS FOR THEIR PREPARATION'; and (iii) 'RAPID DISSOLVABLE ORAL FILM FOR DELIVERING HERBAL EXTRACTS WITH OR WITHOUT OTHER PHARMACEUTICAL AGENTS'. Further, our Company has also a National Phase Application in Malaysia for registration of 'PELLETS OF HERBAL EXTRACTS AND THE PROCESS OF PREPARING PELLETS'. Further, our Company has filed separate patent applications for the above inventions with the Patent Office, Mumbai.

We possess necessary skills, technological and intellectual property capabilities, including in-house infrastructure and R&D capabilities, to develop allopathic and herbal formulations which can be submitted to regulatory authorities for marketing and sale approval. Our regulatory team has also developed processes and has the capabilities to file product registrations in semi-regulated markets.

Analytical Strength: 


 

  Click on image to see enlarged view

 
< Prev   Next >

UNIQUE INNOVATIONS

Other Links...

 



You are here  :Home arrow Facilities arrow Research & Development Centre
Unijules Life Sciences Limited is proposing – subject to receipt of requisite approvals, market conditions and other considerations - a public issue of its equity shares. The Draft Red Herring Prospectus has been filed by the Company with SEBI and is available on SEBI website at www.sebi.gov.in as well as on the Book Running Lead Managers website www.rathi.com.

Investors should note that an investment in equity shares involves a high degree of risk and for details relating to the same, please refer to the section titled ‘Risk Factors’ of the DRHP.